A study to evaluate the safety and efficacy of Ponatinib in patients with chronic myeloid leukaemia who are intolerant to previous TKIs
Latest Information Update: 23 Jul 2020
At a glance
- Drugs Ponatinib (Primary)
- Indications Chronic myeloid leukaemia
- Focus Therapeutic Use
- 23 Jul 2020 New trial record
- 21 Jun 2020 Results presented at the 25th Congress of the European Haematology Association